|
🐜
|
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
18 auth.
J. Vermorken,
R. Mesía,
F. Rivera,
É. Remenár,
A. Kawecki,
S. Rottey,
J. Erfán,
D. Zabolotnyy,
H. Kienzer,
D. Cupissol,
...
F. Peyrade,
M. Benasso,
I. Vynnychenko,
D. de Raucourt,
C. Bokemeyer,
A. Schueler,
N. Amellal,
R. Hitt
|
11 |
2008 |
11
🐜
|
|
🐜
|
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
18 auth.
J. Vermorken,
É. Remenár,
C. V. van Herpen,
T. Gorlia,
R. Mesía,
M. Degardin,
J. Stewart,
S. Jelić,
J. Betka,
J. Preiss,
...
D. van den Weyngaert,
A. Awada,
D. Cupissol,
H. Kienzer,
A. Rey,
Isabelle Desaunois,
J. Bernier,
J. Lefebvre
|
10 |
2007 |
10
🐜
|
|
🐜
|
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
16 auth.
N. Penel,
B. Bui,
J. Bay,
D. Cupissol,
I. Ray-Coquard,
S. Piperno-Neumann,
P. Kerbrat,
C. Fournier,
S. Taieb,
M. Jimenez,
...
N. Isambert,
F. Peyrade,
C. Chevreau,
E. Bompas,
E. Brain,
J. Blay
|
9 |
2008 |
9
🐜
|
|
🐜
|
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
17 auth.
J. Blay,
A. Le Cesne,
I. Ray-Coquard,
B. Bui,
F. Duffaud,
C. Delbaldo,
A. Adenis,
P. Viens,
M. Ríos,
E. Bompas,
...
D. Cupissol,
C. Guillemet,
P. Kerbrat,
J. Fayette,
S. Chabaud,
P. Berthaud,
D. Pérol
|
8 |
2007 |
8
🐜
|
|
🐜
|
Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1·5 mm without clinically detectable node metastases
13 auth.
J. Grob,
B. Dréno,
P. Salmoniere,
M. Delaunay,
D. Cupissol,
B. Guillot,
P. Souteyrand,
B. Sassolas,
J. Césarini,
Sylvie Lionnet,
...
C. Lok,
C. Chastang,
J. Bonerandi
|
8 |
1998 |
8
🐜
|
|
🐜
|
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
19 auth.
J. Machiels,
R. Haddad,
J. Fayette,
L. Licitra,
M. Tahara,
J. Vermorken,
P. Clement,
T. Gauler,
D. Cupissol,
J. Grau,
...
J. Guigay,
F. Caponigro,
G. de Castro,
L. de Souza Viana,
U. Keilholz,
J. D. Del Campo,
X. Cong,
E. Ehrnrooth,
E. Cohen
|
8 |
2015 |
8
🐜
|
|
🐜
|
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.
14 auth.
Axel Le Cesne,
I. Ray-Coquard,
B. Bui,
A. Adenis,
M. Ríos,
F. Bertucci,
F. Duffaud,
C. Chevreau,
D. Cupissol,
A. Cioffi,
...
J. Emile,
S. Chabaud,
D. Pérol,
J. Blay
|
8 |
2010 |
8
🐜
|
|
🐜
|
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
15 auth.
Nicolas Penel,
A. Cesne,
B. Bui,
D. Pérol,
E. Brain,
I. Ray-Coquard,
C. Guillemet,
C. Chevreau,
D. Cupissol,
S. Chabaud,
...
M. Jimenez,
F. Duffaud,
S. Piperno-Neumann,
L. Mignot,
J. Blay
|
7 |
2011 |
7
🐜
|
|
🐜
|
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
30 auth.
O. Mir,
T. Brodowicz,
A. Italiano,
J. Wallet,
J. Blay,
F. Bertucci,
C. Chevreau,
S. Piperno-Neumann,
E. Bompas,
S. Salas,
C. Perrin,
C. Delcambre,
B. Liegl-Atzwanger,
M. Toulmonde,
S. Dumont,
...
I. Ray-Coquard,
S. Clisant,
S. Taieb,
C. Guillemet,
M. Ríos,
O. Collard,
L. Bozec,
D. Cupissol,
E. Saâda-Bouzid,
C. Lemaignan,
W. Eisterer,
N. Isambert,
L. Chaigneau,
A. Cesne,
N. Penel
|
7 |
2016 |
7
🐜
|
|
🐜
|
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).
14 auth.
P. Pautier,
A. Floquet,
N. Penel,
S. Piperno-Neumann,
N. Isambert,
A. Rey,
E. Bompas,
A. Cioffi,
C. Delcambre,
D. Cupissol,
...
F. Collin,
J. Blay,
M. Jimenez,
F. Duffaud
|
7 |
2012 |
7
🐜
|
|
🐜
|
Improved survival using specialized multidisciplinary board in sarcoma patients
30 auth.
Jean-Yves Blay,
P. Soibinet,
Nicolas Penel,
E. Bompas,
F. Duffaud,
E. Stoeckle,
O. Mir,
J. Adam,
C. Chevreau,
S. Bonvalot,
M. Ríos,
P. Kerbrat,
D. Cupissol,
P. Anract,
F. Gouin,
...
J. Kurtz,
C. Lebbé,
N. Isambert,
F. Bertucci,
M. Toumonde,
A. Thyss,
S. Piperno-Neumann,
P. Dubray-Longeras,
P. Meeus,
F. Ducimetière,
A. Giraud,
J. Coindre,
I. Ray-Coquard,
A. Italiano,
A. Cesne
|
7 |
2017 |
7
🐜
|
|
🐜
|
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
18 auth.
I. Ray-Coquard,
A. Italiano,
E. Bompas,
A. Le Cesne,
Y. Robin,
C. Chevreau,
J. Bay,
G. Bousquet,
S. Piperno-Neumann,
N. Isambert,
...
L. Lemaitre,
C. Fournier,
E. Gauthier,
O. Collard,
D. Cupissol,
S. Clisant,
J. Blay,
N. Penel
|
7 |
2012 |
7
🐜
|
